-
1
-
-
72249117763
-
-
(a) E. C. Lawson, D. K. Luci, S. Ghosh, W. A. Kinney, C. H. Reynolds, J. Qi, C. E. Smith, Y. Wang, L. K. Minor, B. J. Haertlein, T. J. Parry, B. P. Damiano, B. E. Maryanoff, J. Med. Chem. 2009, 52, 7432
-
(2009)
J. Med. Chem
, vol.52
, pp. 7432
-
-
Lawson, E.C.1
Luci, D.K.2
Ghosh, S.3
Kinney, W.A.4
Reynolds, C.H.5
Qi, J.6
Smith, C.E.7
Wang, Y.8
Minor, L.K.9
Haertlein, B.J.10
Parry, T.J.11
Damiano, B.P.12
Maryanoff, B.E.13
-
2
-
-
70349971644
-
-
(b) E.-Y. Moon, J.-M. Oh, Y.-H. Kim, I.-J. Ryoo, I.-D. Yoo, Biol. Pharm. Bull. 2009, 32, 1689
-
(2009)
Biol. Pharm. Bull
, vol.32
, pp. 1689
-
-
Moon, E.-Y.1
Oh, J.-M.2
Kim, Y.-H.3
Ryoo, I.-J.4
Yoo, I.-D.5
-
3
-
-
0000025733
-
-
(c) H. M. Botero Cid, C. Tränkle, K. Baumann, R. Pick, E. Mies-Klomfass, E. Kostenis, K. Mohr, U. Holzgrabe, J. Med. Chem. 2000, 43, 2155;
-
(2000)
J. Med. Chem
, vol.43
, pp. 2155
-
-
Botero Cid, H.M.1
Tränkle, C.2
Baumann, K.3
Pick, R.4
Mies-Klomfass, E.5
Kostenis, E.6
Mohr, K.7
Holzgrabe, U.8
-
4
-
-
0031893482
-
-
(d) Z.-P. Zhuang, M.-P. Kung, M. Mu, H. F. Kung, J. Med. Chem. 1998, 41, 157
-
(1998)
J. Med. Chem
, vol.41
, pp. 157
-
-
Zhuang, Z.-P.1
Kung, M.-P.2
Mu, M.3
Kung, H.F.4
-
5
-
-
0029841520
-
-
(e) J. L. Wood, B. M. Stoltz, S. N. Goodman, J. Am. Chem. Soc. 1996, 118, 10656.
-
(1996)
J. Am. Chem. Soc
, vol.118
, pp. 10656
-
-
Wood, J.L.1
Stoltz, B.M.2
Goodman, S.N.3
-
6
-
-
0027437245
-
-
(a) Z. Hussein, D. J. Mulford, B. A. Bopp, G. R. Granneman, Br. J. Clin. Pharmacol. 1993, 36, 357
-
(1993)
Br. J. Clin. Pharmacol
, vol.36
, pp. 357
-
-
Hussein, Z.1
Mulford, D.J.2
Bopp, B.A.3
Granneman, G.R.4
-
7
-
-
33747336252
-
-
(b) N. Kawanishi, T. Sugimoto, J. Shibata, K. Nakamura, K. Masutani, M. Ikuta, H. Hirai, Bioorg. Med. Chem. Lett. 2006, 16, 5122
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 5122
-
-
Kawanishi, N.1
Sugimoto, T.2
Shibata, J.3
Nakamura, K.4
Masutani, K.5
Ikuta, M.6
Hirai, H.7
-
8
-
-
0032537535
-
-
(c) T. R. Belliotti, W. A. Brink, S. R. Kesten, J. R. Rubin, D. J. Wustrow, K. T. Zoski, S. Z. Whetzel, A. E. Corbin, T. A. Pugsley, T. G. Heffner, L. D. Wise, Bioorg. Med. Chem. Lett. 1998, 8, 1499
-
(1998)
Bioorg. Med. Chem. Lett
, vol.8
, pp. 1499
-
-
Belliotti, T.R.1
Brink, W.A.2
Kesten, S.R.3
Rubin, J.R.4
Wustrow, D.J.5
Zoski, K.T.6
Whetzel, S.Z.7
Corbin, A.E.8
Pugsley, T.A.9
Heffner, T.G.10
Wise, L.D.11
-
9
-
-
0033598368
-
-
(d) J. Ren, R. M. Esnouf, A. L. Hopkins, D. I. Stuart, D. K. Stammers, J. Med. Chem. 1999, 42, 3845.
-
(1999)
J. Med. Chem
, vol.42
, pp. 3845
-
-
Ren, J.1
Esnouf, R.M.2
Hopkins, A.L.3
Stuart, D.I.4
Stammers, D.K.5
-
10
-
-
0025348717
-
-
(a) R. Grigg, M. J. R. Dorrity, J. F. Malone, T. Mongkolaussavaratana, W. D. J. A. Norbert, V. Sridharan, Tetrahedron Lett. 1990, 31, 3075
-
(1990)
Tetrahedron Lett
, vol.31
, pp. 3075
-
-
Grigg, R.1
Dorrity, M.J.R.2
Malone, J.F.3
Mongkolaussavaratana, T.4
Norbert, W.D.J.A.5
Sridharan, V.6
-
11
-
-
0030908612
-
-
(b) S. M. Allin, C. J. Northfield, M. I. Page, A. M. Z. Slawin, Tetrahedron Lett. 1997, 38, 3627
-
(1997)
Tetrahedron Lett
, vol.38
, pp. 3627
-
-
Allin, S.M.1
Northfield, C.J.2
Page, M.I.3
Slawin, A.M.Z.4
-
12
-
-
0035680653
-
-
(c) D. Enders, V. Braig, G. Raabe, Can. J. Chem. 2001, 79, 1528
-
(2001)
Can. J. Chem
, vol.79
, pp. 1528
-
-
Enders, D.1
Braig, V.2
Raabe, G.3
-
13
-
-
0036006962
-
-
(d) H. McAlonan, J. P. Murphy, M. Nieuwenhuyzen, K. Reynolds, P. K. S. Sarma, P. J. Stevenson, N. Thompson, J. Chem. Soc., Perkin Trans. 1 2002, 69
-
(2002)
J. Chem. Soc. Perkin Trans
, vol.1
, pp. 69
-
-
McAlonan, H.1
Murphy, J.P.2
Nieuwenhuyzen, M.3
Reynolds, K.4
Sarma, P.K.S.5
Stevenson, P.J.6
Thompson, N.7
-
14
-
-
13844294123
-
-
(e) E. Deniau, D. Enders, A. Couture, P. Grandclaudon, Tetrahedron: Asymmetry 2005, 16, 875
-
(2005)
Tetrahedron: Asymmetry
, vol.16
, pp. 875
-
-
Deniau, E.1
Enders, D.2
Couture, A.3
Grandclaudon, P.4
-
15
-
-
38349022144
-
-
see also ref. [7]
-
(f) M. Lamblin, A. Couture, E. Deniau, P. Grandclaudon, Tetrahedron: Asymmetry 2008, 19, 111 see also ref. [7].
-
(2008)
Tetrahedron: Asymmetry
, vol.19
, pp. 111
-
-
Lamblin, M.1
Couture, A.2
Deniau, E.3
Grandclaudon, P.4
-
16
-
-
78349235206
-
-
S. Guo, Y. Xie, X. Hu, C. Xia, H. Huang, Angew. Chem. 2010, 122, 2788;
-
(2010)
Angew. Chem
, vol.122
, pp. 2788
-
-
Guo, S.1
Xie, Y.2
Hu, X.3
Xia, C.4
Huang, H.5
-
18
-
-
79551558446
-
-
(a) X. Yu, A. Lu, Y. Wang, G. Wu, H. Song, Z. Zhou, C. Tang, Eur. J. Org. Chem. 2011, 892
-
(2011)
Eur. J. Org. Chem
, pp. 892
-
-
Yu, X.1
Lu, A.2
Wang, Y.3
Wu, G.4
Song, H.5
Zhou, Z.6
Tang, C.7
-
19
-
-
79956372069
-
-
(b) X. Yu, Y. Wang, G. Wu, H. Song, Z. Zhou, C. Tang, Eur. J. Org. Chem. 2011, 3060.
-
(2011)
Eur. J. Org. Chem
, vol.3060
-
-
Yu, X.1
Wang, Y.2
Wu, G.3
Song, H.4
Zhou, Z.5
Tang, C.6
-
20
-
-
84863012114
-
-
M.-W. Chen, Q.-A. Chen, Y. Duan, Z.-S. Ye, Y.-G. Zhou, Chem. Commun. 2012, 48, 1698.
-
(2012)
Chem. Commun
, vol.48
, pp. 1698
-
-
Chen, M.-W.1
Chen, Q.-A.2
Duan, Y.3
Ye, Z.-S.4
Zhou, Y.-G.5
-
21
-
-
12344317278
-
-
(a) D. L. Comins, S. Schilling, Y. Zhang, Org. Lett. 2005, 7, 95
-
(2005)
Org. Lett
, vol.7
, pp. 95
-
-
Comins, D.L.1
Schilling, S.2
Zhang, Y.3
-
23
-
-
0037124518
-
-
(c) J. Pérard-Viret, A. Tomas, J. Royer, Tetrahedron 2002, 58, 5103
-
(2002)
Tetrahedron
, vol.58
, pp. 5103
-
-
Pérard-Viret, J.1
Tomas, A.2
Royer, J.3
-
24
-
-
0037128491
-
-
for racemic reactions of isoindolinones with aldehydes via benzylic carbanion formation with stoichiometric amounts of LDA (LDA=lithium diisopropylamide), see: 1) A. Couture, E. Deniau, P. Grandclaudon, C. Hoarau, V. Rys, Tetrahedron Lett. 2002, 43, 2207.
-
(2002)
Rys, Tetrahedron Lett
, vol.43
, pp. 2207
-
-
Couture, A.1
Deniau, E.2
Grandclaudon, P.3
Hoarau, V.C.4
-
25
-
-
77954271846
-
-
For a general review on enantioselective synthesis of tetrasubstituted oxindoles, see: a) F. Zhou, Y.-L. Liu, J. Zhou, Adv. Synth. Catal. 2010, 352, 1381
-
(2010)
Adv. Synth. Catal
, vol.352
, pp. 1381
-
-
Zhou, F.1
Liu, Y.-L.2
Zhou, J.3
-
26
-
-
83755168278
-
-
for selected leading examples using oxindoles for asymmetric C-C bond formation, see: 1) B. M. Trost, J. Xie, J. D. Sieber, J. Am. Chem. Soc. 2011, 133, 20611, and references therein
-
(2011)
J. Am. Chem. Soc
, vol.133
, pp. 20611
-
-
Trost, B.M.1
Xie, J.2
Sieber, J.D.3
-
27
-
-
77149159188
-
-
S. Ma, X. Han, S. Krishnan, S. C. Virgil, B. M. Stoltz, Angew. Chem. 2009, 121, 8181
-
(2009)
Angew. Chem
, vol.121
, pp. 8181
-
-
Ma, S.1
Han, X.2
Krishnan, S.3
Virgil, S.C.4
Stoltz, B.M.5
-
29
-
-
70450177483
-
-
R. He, S. Shirakawa, K. Maruoka, J. Am. Chem. Soc. 2009, 131, 16620
-
(2009)
J. Am. Chem. Soc
, vol.131
, pp. 16620
-
-
He, R.1
Shirakawa, S.2
Maruoka, K.3
-
30
-
-
67649600829
-
-
T. Bui, S. Syed, C. F. Barbas, III, J. Am. Chem. Soc. 2009, 131, 8758
-
(2009)
J. Am. Chem. Soc
, vol.131
, pp. 8758
-
-
Bui, T.1
Syed, S.2
Barbas Iii, C.F.3
-
32
-
-
67649948776
-
-
For early reports using oxindoles as nucleophiles by our group in collaboration with Prof. Shibasaki, see: a) Y. Kato, M. Furutachi, Z. Chen, H. Mitsunuma, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 9168
-
(2009)
J. Am. Chem. Soc
, vol.131
, pp. 9168
-
-
Kato, Y.1
Furutachi, M.2
Chen, Z.3
Mitsunuma, H.4
Matsunaga, S.5
Shibasaki, M.6
-
33
-
-
77950340760
-
-
(b) S. Mouri, Z. Chen, H. Mitsunuma, M. Furutachi, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2010, 132, 1255
-
(2010)
J. Am. Chem. Soc
, vol.132
, pp. 1255
-
-
Mouri, S.1
Chen, Z.2
Mitsunuma, H.3
Furutachi, M.4
Matsunaga, S.5
Shibasaki, M.6
-
35
-
-
84863011371
-
-
(d) S. Mouri, Z. Chen, S. Matsunaga, M. Shibasaki, Heterocycles 2012, 84, 879
-
(2012)
Heterocycles
, vol.84
, pp. 879
-
-
Mouri, S.1
Chen, Z.2
Matsunaga, S.3
Shibasaki, M.4
-
36
-
-
84862595935
-
-
DOI: 10.1002/anie.201201132
-
(e) H. Mitsunuma, M. Shibasaki, M. Kanai, S. Matsunaga, S. Angew. Chem. Int. Ed. , DOI: 10.1002/anie.201201132.
-
Chem. Int. Ed
-
-
Mitsunuma, H.1
Shibasaki, M.2
Kanai, M.3
Matsunaga, S.4
Angew, S.5
-
39
-
-
33846999920
-
-
(b) J. Esquivias, R. Gómez Arrayás, J. C. Carretero, J. Am. Chem. Soc. 2007, 129, 1480, and references therein
-
(2007)
J. Am. Chem. Soc
, vol.129
, pp. 1480
-
-
Esquivias, J.1
Gómez Arrayás, R.2
Carretero, J.C.3
-
40
-
-
33748756432
-
-
(c) S. Nakamura, H. Nakashima, H. Sugimoto, N. Shibata, T. Toru, Tetrahedron Lett. 2006, 47, 7599
-
(2006)
Tetrahedron Lett
, vol.47
, pp. 7599
-
-
Nakamura, S.1
Nakashima, H.2
Sugimoto, H.3
Shibata, N.4
Toru, T.5
-
41
-
-
48249106576
-
-
(d) S. Nakamura, H. Nakashima, H. Sugimoto, H. Sano, M. Hattori, N. Shibata, T. Toru, Chem. Eur. J. 2008, 14, 2145, and references therein
-
(2008)
Chem. Eur. J
, vol.14
, pp. 2145
-
-
Nakamura, S.1
Nakashima, H.2
Sugimoto, H.3
Sano, H.4
Hattori, M.5
Shibata, N.6
Toru, T.7
-
42
-
-
34547803869
-
-
(e) H. Morimoto, G. Lu, N. Aoyama, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2007, 129, 9588
-
(2007)
J. Am. Chem. Soc
, vol.129
, pp. 9588
-
-
Morimoto, H.1
Lu, G.2
Aoyama, N.3
Matsunaga, S.4
Shibasaki, M.5
-
43
-
-
65349192729
-
-
(f) G. Lu, H. Morimoto, S. Matsunaga, M. Shibasaki, Angew. Chem. 2008, 120, 6953
-
(2008)
Angew. Chem
, vol.120
, pp. 6953
-
-
Lu, G.1
Morimoto, H.2
Matsunaga, S.3
Shibasaki, M.4
-
45
-
-
84862614644
-
-
2-pyridinesulfonyl imine, diphenylphosphinoyl imine, and Boc-imine resulted in much less satisfactory yield and/or enantioselectivity when using Bu2Mg/Schiff base catalysts
-
Other imines, such as Ts-imine (Ts=p-toluenesulfonyl), 2-pyridinesulfonyl imine, diphenylphosphinoyl imine, and Boc-imine resulted in much less satisfactory yield and/or enantioselectivity when using Bu2Mg/Schiff base catalysts.
-
Other Imines, Such As Ts-imine (Ts=p-toluenesulfonyl)
-
-
-
46
-
-
84862614267
-
For the utility of MeO-substituted Schiff base 2a and related ligands in asymmetric catalysis, see: A) B
-
For the utility of MeO-substituted Schiff base 2a and related ligands in asymmetric catalysis, see: a) B. Wu, J. C. Gallucci, J. R. Parquette, T. V. RajanBabu, Angew. Chem. 2009, 121, 1146
-
(2009)
Wu, J
, Issue.121
, pp. 1146
-
-
Gallucci, C.1
Parquette, J.R.2
RajanBabu, T.V.3
-
47
-
-
59049103335
-
-
(b) Angew. Chem. Int. Ed. 2009, 48, 1126
-
(2009)
Angew. Chem. Int. Ed
, vol.48
, pp. 1126
-
-
-
48
-
-
67650525098
-
-
(c) H. Mihara, Y. Xu, N. E. Shepherd, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 8384
-
(2009)
J. Am. Chem. Soc
, vol.131
, pp. 8384
-
-
Mihara, H.1
Xu, Y.2
Shepherd, N.E.3
Matsunaga, S.4
Shibasaki, M.5
-
49
-
-
79954463686
-
-
(d) Y. Xu, L. Lin, M. Kanai, S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2011, 133, 5791.
-
(2011)
J. Am. Chem. Soc
, vol.133
, pp. 5791
-
-
Xu, Y.1
Lin, L.2
Kanai, M.3
Matsunaga, S.4
Shibasaki, M.5
-
50
-
-
72249092076
-
-
For the utility of Mg/Schiff base 2e catalyst in other reactions, see: a) T. Yoshino, H. Morimoto, G. Lu. S. Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 17082
-
(2009)
J. Am. Chem. Soc
, vol.131
, pp. 17082
-
-
Yoshino, T.1
Morimoto, H.2
Lu., G.3
Matsunaga, S.4
Shibasaki, M.5
-
51
-
-
84255195634
-
-
(b) G. Lu, T. Yoshino, H. Morimoto, S. Matsunaga, M. Shibasaki, Angew. Chem. 2011, 123, 4474
-
(2011)
Angew. Chem
, vol.123
, pp. 4474
-
-
Lu, G.1
Yoshino, T.2
Morimoto, H.3
Matsunaga, S.4
Shibasaki, M.5
-
54
-
-
84862608762
-
-
such as BINOL derivatives (BINOL=1,1-bi-2- naphtho1) and chiral bis-sulfonamides, resulted in poor reactivity and/or stereoselectivity
-
Other chiral ligands, such as BINOL derivatives (BINOL=1,1-bi-2- naphtho1) and chiral bis-sulfonamides, resulted in poor reactivity and/or stereoselectivity.
-
Other Chiral Ligands
-
-
-
56
-
-
84862608763
-
-
CCDC-870068 (syn-5a1) and CCDC-870069 (anti-5a1) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via
-
CCDC-870068 (syn-5a1) and CCDC-870069 (anti-5a1) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data-request/cif.
-
-
-
-
57
-
-
84862614565
-
-
Because the structure of the catalyst, prepared from Bu2Mg/Schiff base 2 (Figure 2) in a ratio of 1:1, has not been clarified, it is difficult to propose the transition state model to explain the stereochemistry of products
-
Because the structure of the catalyst, prepared from Bu2Mg/Schiff base 2 (Figure 2) in a ratio of 1:1, has not been clarified, it is difficult to propose the transition state model to explain the stereochemistry of products. The Bu2Mg/Schiff base 2 1:1 mixture is speculated to have an oligomeric structure, see ref. [14b].
-
The Bu2Mg/Schiff Base rfvn1 2 1:1 Mixture Is Speculated to Have An Oligomeric Structure, See Ref. [14b]
-
-
|